Sphingosine analogue AAL-R increases TLR7-mediated dendritic cell responses via p38 and type I IFN signaling pathways

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4759-4768

  Seo, Young Jin ^a   Pritzl, Curtis J ^a   Vijayan, Madhuvanthi ^a   Blake, Celeste R ^a   McClain, Mariah E ^a   Hahm, Bumsuk ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SPHINGOSINE DERIVATIVE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 7;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON TYPE I; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROPYLENE GLYCOLS; SIGNAL TRANSDUCTION; SPHINGOSINE; TOLL-LIKE RECEPTOR 7; UP-REGULATION;

EID: 84861152862     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102754     Document Type: Article

References (63)

1. Rosen, H., and E. J. Goetzl. 2005. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5: 560-570. (Pubitemid 40961333)
2. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23: 127-159. (Pubitemid 40563167)
3. Srinivasan, S., D. T. Bolick, D. Lukashev, C. Lappas, M. Sitkovsky, K. R. Lynch, and C. C. Hedrick. 2008. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69. Diabetes 57: 484-493.
4. Takabe, K., S. W. Paugh, S. Milstien, and S. Spiegel. 2008. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60: 181-195. (Pubitemid 351962008)
5. Fyrst, H., and J. D. Saba. 2010. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat. Chem. Biol. 6: 489-497.
6. Budde, K., M. Schütz, P. Glander, H. Peters, J. Waiser, L. Liefeldt, H. H. Neumayer, and T. Böhler. 2006. FTY720 (fingolimod) in renal transplantation. Clin. Transplant. 20(Suppl 17): 17-24. (Pubitemid 44697897)
7. Sawicka, E., C. Zuany-Amorim, C. Manlius, A. Trifilieff, V. Brinkmann, D. M. Kemeny, and C. Walker. 2003. Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J. Immunol. 171: 6206-6214. (Pubitemid 37467244)
8. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, T. Müller, T. Soullié, M. A. Willart, D. Hijdra, H. C. Hoogsteden, and B. N. Lambrecht. 2006. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest. 116: 2935-2944. (Pubitemid 44684478)
9. Matsuura, M., T. Imayoshi, and T. Okumoto. 2000. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int. J. Immunopharmacol. 22: 323-331. (Pubitemid 30109509)
10. Maki, T., R. Gottschalk, and A. P. Monaco. 2002. Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice. Transplantation 74: 1684-1686. (Pubitemid 36019318)
11. Horga, A., and X. Montalban. 2008. FTY720 (fingolimod) for relapsing multiple sclerosis. Expert Rev. Neurother. 8: 699-714. (Pubitemid 351656821)
12. Brinkmann, V., A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin. 2010. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9: 883-897.
13. Marsolais, D., B. Hahm, K. H. Edelmann, K. B. Walsh, M. Guerrero, Y. Hatta, Y. Kawaoka, E. Roberts, M. B. Oldstone, and H. Rosen. 2008. Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza. Mol. Pharmacol. 74: 896-903.
14. Marsolais, D., B. Hahm, K. B. Walsh, K. H. Edelmann, D. McGavern, Y. Hatta, Y. Kawaoka, H. Rosen, and M. B. Oldstone. 2009. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc. Natl. Acad. Sci. USA 106: 1560-1565.
15. Walsh, K. B., J. R. Teijaro, P. R. Wilker, A. Jatzek, D. M. Fremgen, S. C. Das, T. Watanabe, M. Hatta, K. Shinya, M. Suresh, et al. 2011. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 108: 12018-12023.
16. Maceyka, M., S. G. Payne, S. Milstien, and S. Spiegel. 2002. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 1585: 193-201. (Pubitemid 36096858)
17. Don, A. S., C. Martinez-Lamenca, W. R. Webb, R. L. Proia, E. Roberts, and H. Rosen. 2007. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J. Biol. Chem. 282: 15833-15842. (Pubitemid 47093290)
18. Brinkmann, V., M. D. Davis, C. E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277: 21453-21457. (Pubitemid 34952287)
19. Marsolais, D., and H. Rosen. 2009. Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules. Nat. Rev. Drug Discov. 8: 297-307.
20. Billich, A., F. Bornancin, P. Dévay, D. Mechtcheriakova, N. Urtz, and T. Baumruker. 2003. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278: 47408-47415. (Pubitemid 37523181)
21. Sanchez, T., T. Estrada-Hernandez, J. H. Paik, M. T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278: 47281-47290. (Pubitemid 37452317)
22. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349. (Pubitemid 34303689)
23. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360. (Pubitemid 38133663)
24. Rosen, H., P. Gonzalez-Cabrera, D. Marsolais, S. Cahalan, A. S. Don, and M. G. Sanna. 2008. Modulating tone: the overture of S1P receptor immunotherapeutics. Immunol. Rev. 223: 221-235. (Pubitemid 351986190)
25. Czeloth, N., G. Bernhardt, F. Hofmann, H. Genth, and R. Förster. 2005. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol. 175: 2960-2967. (Pubitemid 41170513)
26. Müller, H., S. Hofer, N. Kaneider, H. Neuwirt, B. Mosheimer, G. Mayer, G. Konwalinka, C. Heufler, and M. Tiefenthaler. 2005. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur. J. Immunol. 35: 533-545. (Pubitemid 40331330)
27. Jary, E., T. Bee, S. R. Walker, S. K. Chung, K. C. Seo, J. C. Morris, and A. S. Don. 2010. Elimination of a hydroxyl group in FTY720 dramatically improves the phosphorylation rate. Mol. Pharmacol. 78: 685-692.
28. Steinman, R. M. 2008. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 29: 319-324.
29. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
30. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
31. Akira, S. 2006. TLR signaling. Curr. Top. Microbiol. Immunol. 311: 1-16. (Pubitemid 47413193)
32. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
33. Mancuso, G., M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, G. Teti, and C. Beninati. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10: 587-594.
34. Kadowaki, N., S. Antonenko, and Y. J. Liu. 2001. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J. Immunol. 166: 2291-2295. (Pubitemid 32173460)
35. Verthelyi, D., K. J. Ishii, M. Gursel, F. Takeshita, and D. M. Klinman. 2001. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166: 2372-2377. (Pubitemid 32173471)
36. Seo, Y. J., and B. Hahm. 2010. Type I interferon modulates the battle of host immune system against viruses. Adv. Appl. Microbiol. 73: 83-101.
37. Taniguchi, T., and A. Takaoka. 2002. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14: 111-116. (Pubitemid 34085114)
38. Grandvaux, N., B. R. tenOever, M. J. Servant, and J. Hiscott. 2002. The interferon antiviral response: from viral invasion to evasion. Curr. Opin. Infect. Dis. 15: 259-267. (Pubitemid 34548188)
39. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603. (Pubitemid 38481202)
40. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. M. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23: 1956-1962. (Pubitemid 23236793)
41. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
42. Hahm, B., M. J. Trifilo, E. I. Zuniga, and M. B. Oldstone. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22: 247-257. (Pubitemid 40255715)
43. Heil, F., P. Ahmad-Nejad, H. Hemmi, H. Hochrein, F. Ampenberger, T. Gellert, H. Dietrich, G. Lipford, K. Takeda, S. Akira, et al. 2003. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33: 2987-2997. (Pubitemid 37428331)
44. Hahm, B., J. H. Cho, and M. B. Oldstone. 2007. Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 358: 251-257. (Pubitemid 46157036)
45. Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85-95. (Pubitemid 36071561)
46. Lee, J., T. H. Chuang, V. Redecke, L. She, P. M. Pitha, D. A. Carson, E. Raz, and H. B. Cottam. 2003. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 100: 6646-6651. (Pubitemid 36666635)
47. Beignon, A. S., K. McKenna, M. Skoberne, O. Manches, I. DaSilva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, and N. Bhardwaj. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115: 3265-3275. (Pubitemid 41567591)
48. Jung, A., H. Kato, Y. Kumagai, H. Kumar, T. Kawai, O. Takeuchi, and S. Akira. 2008. lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82: 196-206. (Pubitemid 350309136)
49. Markowicz, S., and E. G. Engleman. 1990. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J. Clin. Invest. 85: 955-961. (Pubitemid 20087502)
50. Spiegel, S., and S. Milstien. 2011. The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11: 403-415.
51. Aaronson, D. S., and C. M. Horvath. 2002. A road map for those who don't know JAK-STAT. Science 296: 1653-1655. (Pubitemid 34579157)
52. Pitha-Rowe, I. F., and P. M. Pitha. 2007. Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev. 18: 409-417. (Pubitemid 47302838)
53. Hsieh, H. L., C. C. Sun, C. B. Wu, C. Y. Wu, W. H. Tung, H. H. Wang, and C. M. Yang. 2008. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. J. Cell. Biochem. 103: 1732-1746.
54. Heo, K., K. A. Park, Y. H. Kim, S. H. Kim, Y. S. Oh, I. H. Kim, S. H. Ryu, and P. G. Suh. 2009. Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. BMB Rep. 42: 685-690.
55. Spiegel, S., and S. Milstien. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4: 397-407. (Pubitemid 36565571)
56. Panne, D., T. Maniatis, and S. C. Harrison. 2004. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J. 23: 4384-4393. (Pubitemid 39601963)
57. Reimer, T., M. Schweizer, and T. W. Jungi. 2007. Stimulation-specific contribution of p38 and JNK to IFN-beta gene expression in human macrophages. J. Interferon Cytokine Res. 27: 751-755. (Pubitemid 47479859)
58. Venkataraman, K., S. Thangada, J. Michaud, M. L. Oo, Y. Ai, Y. M. Lee, M. Wu, N. S. Parikh, F. Khan, R. L. Proia, and T. Hla. 2006. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem. J. 397: 461-471. (Pubitemid 44187504)
59. Pitson, S. M. 2011. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem. Sci. 36: 97-107.
60. Maceyka, M., H. Sankala, N. C. Hait, H. Le Stunff, H. Liu, R. Toman, C. Collier, M. Zhang, L. S. Satin, A. H. Merrill, Jr., et al. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280: 37118-37129. (Pubitemid 41587796)
61. Garber, K. 2008. Infections cast cloud over Novartis' MS therapy. Nat. Biotechnol. 26: 844-845.
62. Rinaldo, C. R. 2009. Dendritic cell-based human immunodeficiency virus vaccine. J. Intern. Med. 265: 138-158.
63. Inaba, K., J. P. Metlay, M. T. Crowley, and R. M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172: 631-640. (Pubitemid 20248404)